Here’s an interesting story from Australia, recently back in the spotlight. From 1962 to 1979, psychiatrist Harry Bailey, MD, serving as chief psychiatrist at Chelmsford Private Hospital in New South Wales, practiced “deep sleep therapy”, which involved keeping people in barbiturate-induced comas for days or even weeks. Twenty-four of the individuals who received this “treatment”… Continue Reading
Carrie Fisher, Dead at Age 60
Actress Carrie Fisher died on December 27, 2016, at the early age of 60. In a 2001 article on Healthy Place, she was described as “Perhaps one of manic-depression’s best-known champions…” Here’s another quote from the same article: “I’m fine, but I’m bipolar. I’m on seven medications, and I take medication three times a day…. Continue Reading
Allen Frances on the Benefits of “Antipsychotics”
On February 1, Allen Frances, MD, published an interesting article on the Huffington Post blog. The article is called Do Antipsychotics Help or Harm Psychotic Symptoms?, and is a response to Robert Whitaker’s post of January 27: “Me, Allen Frances, and Climbing Out of a Pigeonhole. This post, in turn, was a response to Dr…. Continue Reading
Allen Frances ‘Replies’
BACKGROUND On June 19, 2015, I published a post titled Allen Frances’ Ties to Johnson & Johnson. In that post, I set out some very serious allegations against Dr. Frances. I drew these allegations from a document titled Special Witness Report dated October 15, 2010. The report was written by David Rothman, PhD, Professor of… Continue Reading
Allen Frances’ Ties to Johnson & Johnson
INTRODUCTION I recently came across an article titled Diagnosisgate: Conflict of Interest at the Top of the Psychiatric Apparatus, by Paula Caplan, PhD. The article was published in Aporia, the University of Ottawa nursing journal, in January 2015. Aporia is “a peer-reviewed, bilingual, and open access journal dedicated to scholarly debates in nursing and the… Continue Reading
Neuroleptic Drugs And Mortality
In November of last year, the Schizophrenia Bulletin published online a research study: Antipsychotic Treatment and Mortality in Schizophrenia, by Minna Torniainen et al. The research was conducted in Sweden. The authors offer the following background for the study: “It is generally believed that long-term use of antipsychotics increases mortality and, especially, the risk of… Continue Reading
The Drugging of Children in Foster Care
It’s no secret that here in America, foster children are being prescribed psychiatric drugs, especially neuroleptics, as a means of controlling their behavior. A great deal has been said and written on the matter. Politicians have declared the practice deplorable. Children’s advocacy groups have expressed concern, and, of course, those of us in the antipsychiatry… Continue Reading
Thomas Insel: “Are Children Overmedicated?”
Thomas Insel, MD, is the Director of the National Institute of Mental Health. In June of last year, he published, on the Director’s Blog, an article titled Are Children Overmedicated? The gist of the article is that children are not being overmedicated, but rather that there is an increase in “severe psychiatric problems” in this… Continue Reading
Neuroleptics and Tardive Dyskinesia in Children
There’s an interesting February 11, 2014, article on Peter Breggin’s website: $1.5 Million Award in Child Tardive Dyskinesia Malpractice. Thanks to Mad in America for the link. Here’s the opening paragraph: “On February 11, 2014 a Chicago jury awarded $1.5 million to an autistic child who developed a severe case of tardive dyskinesia and tardive… Continue Reading
Psychiatry’s Over Reliance On Pharma
I recently read The NIMH-CATIE Schizophrenia Study: What Did We Learn? by Jeffrey Lieberman, MD, and T. Scott Stroup, MD, MPH. The article was published in the American Journal of Psychiatry 168:8, August 2011. Here are two quotes: “When the CATIE study was designed in 1999-2000, the prevailing opinion of researchers and clinicians alike was… Continue Reading
Psychiatric Dogmatism
In November, Joanna Moncrieff, MD, a British psychiatrist who works as a Senior Lecturer in psychiatry at University College London and a practicing consultant psychiatrist, started her own blog. What’s remarkable about this blog is that it is highly critical of psychiatry. Dr. Moncrieff marshals important facts and arguments in this area, and it is… Continue Reading
CAFÉ Study: Real Science or Marketing Exercise?
BACKGROUND On December 8, I received the following question from a reader: (The subject matter is the controversial CAFÉ – Comparisons of Atypicals in First Episode of Psychosis – study. This was the study in which Dan Markingson committed suicide.) “It appears that there was no head-to-head with a control group taking a placebo pill…. Continue Reading
Neuroleptics for Children: Harvard’s Shame
In December 2012, Mark Olfson, MD, et al, published an article in the Archives of General Psychiatry. The title is National Trends in the Office-Based Treatment of Children, Adolescents, and Adults with Antipsychotics. The authors collected data from the National Ambulatory Medical Care Surveys for the period 1993-2009, and looked for trends in antipsychotic prescribing… Continue Reading
Neuroleptics in Nursing Homes
Earlier this year, The American Society of Consultant Pharmacists published a report on the use of neuroleptic drugs in nursing homes. According to this report, 25% of nursing home residents receive neuroleptic drugs. In general, the Centers for Medicare and Medicaid Services (CMS) consider these prescriptions appropriate only if the recipient is psychotic. (Obviously we… Continue Reading